About Index Trending news
Top 50 Pricing
SV Life Sciences

SV Life Sciences

Work at SV Life Sciences? Add yourself to this profile

SV Life Sciences

Life Sciences Venture Capital firm focused on selectively investing in biotech, medical devices and health-care services.


Alexa global traffic share

Twitter followers

50.0M USD Venture capital in Dec, 2014
38.0M USD Series D in Aug, 2015
14.0M USD Series B in Apr, 2012
14.0M USD Venture capital in Apr, 2012
35.0M USD Series E in Aug, 2011
12.4M USD Series A in Jan, 2015
2.4M USD Debt financing in May, 2014
26.0M USD Series D in Dec, 2013
32.4M USD Series B in Nov, 2013
19.3M USD Venture capital in Aug, 2009
Exit: Invisalign for unknown amount on Mar 29, 2011
15.0M USD Series B in Jan, 2016
32.0M USD Series C in Jul, 2016
20.0M USD Series B in Mar, 2005
Exit: Amgen Inc. for unknown amount on Jun 6, 2007
11.9M USD Series A in Aug, 2016
25.0M USD Series A in Aug, 2016
33.2M USD Series A in Sep, 2016
34.0M USD Venture Capital in Nov, 2016
Undisclosed amount Venture Capital in Jan, 2017

Want to see the complete list?
Go Pro!